Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Rohit Mehra is active.

Publication


Featured researches published by Rohit Mehra.


The American Journal of Surgical Pathology | 2015

Diagnosis of Gleason pattern 5 prostate adenocarcinoma on core needle biopsy: an interobserver reproducibility study among urologic pathologists.

Rajal B. Shah; Jianbo Li; Liang Cheng; L. Egevad; Fang Ming Deng; Samson W. Fine; Lakshmi P. Kunju; Jonathan Melamed; Rohit Mehra; Adeboye O. Osunkoya; Gladell P. Paner; Steve S. Shen; Toyonori Tsuzuki; Kiril Trpkov; Wei Tian; Ximing J. Yang; Ming Zhou

Accurate recognition of Gleason pattern 5 (GP5) prostate adenocarcinoma on needle biopsy is critical as it is associated with disease progression and adverse clinical outcome. Despite important implications of this diagnosis, interobserver variation in the diagnosis of GP5 has not been adequately studied. Digital images of 66 prostate adenocarcinoma cases that potentially contained a GP5 component were distributed to 16 urologic pathologists who were asked to classify whether GP5 was present. Each image was initially classified into 1 of 4 morphologic subpatterns by 2 coauthors (R.B.S. and M.Z.): solid nests (15), comedocarcinoma (8), single cells and/or cords (35), and variant morphology (8). Additional features captured included: size (large: >20 cells, medium: 10 to 20 cells, and small: <10 cells) and distribution of nuclei (uniform vs. nonuniform) for nests pattern; intraluminal coagulative tumor necrosis, karyorrhectic debris, and amorphous material for comedocarcinoma pattern; and quantity (⩽5, 6 to 10, and >10) and distribution (clustered vs. intermixed with adjacent well-formed glands) for single cells/cords pattern. Interobserver reproducibility of a diagnosis of GP5 was assessed and the morphologic subpatterns and features were correlated with the consensus diagnosis (defined as 75% agreement). Interobserver reproducibility for overall diagnostic agreement was fair (&kgr;=0.376). Among subpatterns, comedocarcinoma had highest reproducibility (&kgr;=0.499), followed by variant morphology (&kgr;=0.443), single cells/cords (&kgr;=0.369), and nests (&kgr;=0.347). All cases with the following features achieved consensus for GP5: large nests regardless of nuclear distribution; coagulative necrosis with or without karyorrhectic debris; single cells/cords >10 or 6 to 10 in a cluster; and signet ring-like cells in single cells or within nests pattern. A majority of cases with the following features achieved consensus against GP5: medium-size nests; exclusive intraluminal amorphous material; single cells/cords ⩽5; and Paneth cell change. Remaining morphologic features did not reach consensus for or against GP5. A majority (86%) of participants would diagnose a small focus of GP5 only when it is present in >1 level. The diagnostic reproducibility of GP5 within certain morphologies was only fair among urologic pathologists. However, the diagnosis of GP5 was more reproducible when certain restrictive morphologic and quantitative criteria were applied. These findings suggest that additional studies are needed to find highly reproducible features of GP5 associated with documented aggressive clinical outcome.


Archive | 2007

Spink1 as a prostate cancer marker and uses thereof

Arul M. Chinnaiyan; Scott A. Tomlins; Daniel Rhodes; Rohit Mehra


Archive | 2014

SPINK1 AS PROSTATE CANCER MARKER AND USE THEREOF

Arul M. Chinnaiyan; Scott A. Tomlins; Rhodes Daniel R; Rohit Mehra


/data/revues/14702045/v15i13/S1470204514711131/ | 2014

Supplementary material : RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1

John R. Prensner; Shuang Zhao; Nicholas Erho; Matthew Schipper; Matthew K. Iyer; Saravana M. Dhanasekaran; Cristina Magi-Galluzzi; Rohit Mehra; Anirban Sahu; Javed Siddiqui; Elai Davicioni; Robert B. Den; Adam P. Dicker; R. Jeffrey Karnes; John T. Wei; Eric A. Klein; Robert B. Jenkins; Arul M. Chinnaiyan; Felix Y Feng


Archive | 2007

Supplemental Data Integrative Genomics Analysis Reveals Silencing of β-Adrenergic Signaling by Polycomb in Prostate Cancer

Jindan Yu; Qi Cao; Rohit Mehra; Bharathi Laxman; Scott A. Tomlins; Saravana M. Dhanasekaran; Richard Shen; Guoan Chen; David S. Morris; Victor E. Marquez; Rajal B. Shah; Debashis Ghosh; Sooryanarayana Varambally; Arul M. Chinnaiyan


Archive | 2007

Diagnostic et traitement du cancer du sein

Arul M. Chinnaiyan; Daniel Rhodes; Scott A. Tomlins; Rohit Mehra; Sooryanarayana Varambally


Archive | 2006

Wiederkehrende genfusionen bei prostatakrebs

Arul M. Chinnaiyan; Scott A. Tomlins; Daniel Rhodes; Rohit Mehra; Mark A. Rubin; Xiao-Wei Sun; Francesca Demichelis; Sven Perner; Charles M. C. Lee


Archive | 2006

Häufige Genfusionen bei Prostatakrebs

Arul M. Chinnaiyan; Scott A. Tomlins; Daniel Rhodes; Rohit Mehra; Mark A. Rubin; Xiao-Wei Sun; Francesca Demichelis; Sven Perner; Charles M. C. Lee


Archive | 2006

Fusion geniques recurrentes dans le cancer de la prostate

Arul M. Chinnaiyan; Scott A. Tomlins; Daniel Rhodes; Rohit Mehra; Mark A. Rubin; Xiao-Wei Sun; Francesca Demichelis; Sven Perner; Charles M. C. Lee


Archive | 2006

Fusions de gène récurrentes dans le cancer de la prostate

Arul M. Chinnaiyan; Scott A. Tomlins; Daniel Rhodes; Rohit Mehra; Mark A. Rubin; Xiao-Wei Sun; Francesca Demichelis; Sven Perner; Charles M. C. Lee

Collaboration


Dive into the Rohit Mehra's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Daniel Rhodes

Thermo Fisher Scientific

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Francesca Demichelis

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge